Final Results of Phase II Trial (MIRACULUM) of the Novel PD-1 Inhibitor Prolgolimab in Patients with Advanced Melanoma

Saved in:

Bibliographic Details
Published in	Annals of oncology Vol. 30; p. xi44
Main Authors	Tjulandin, S., Fedyanin, M., Demidov, L., Moiseyenko, V., Protsenko, S., Odintsova, S., Semiglazova, T.Y., Zukov, R., Lazarev, S., Andreev, A., Nechaeva, M., Makarova, J., Fadeeva, N., Tarasova, A., Kozlova, O., Shustova, M., Garipov, A., Ivanov, R.
Format	Journal Article
Language	English
Published	01.12.2019
Online Access	Get full text

Loading…

More Information
ISSN:	0923-7534
DOI:	10.1093/annonc/mdz451.027